Sen. majority leader breaks with Bush on stem cells

Senate Majority Leader Bill Frist (R-Tenn.) announced his support for a bill to expand federal financing for embryonic stem cell research. Frist had said as recently as last month that he did not support changes to current limits on funding for stem-cell research, but his change of mind could break the Senate's inertia on the bill. The White House, however, has said it would veto the measure, which has already passed in the House.

- read this article from The New York Times for more

Suggested Articles

Biotech leaders criticized the dismissals of Chinese scientists from U.S. universities in a letter with more than 150 signatures.

In this week's EuroBiotech Report, Merck allies with Themis on vaccine R&D, Juvenescence raises $100 million and GSK files for anemia approval. 

In our EuroBiotech roundup this week, Scancell withdraws IND, Oxurion’s eye drug fails phase 2a and Abivax starts ulcerative colitis trial.